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Abstract
Dermatophytes belonging to the Trichophyton and Arthroderma genera cause skin infections in 
humans and animals. From genome sequencing data, we mined a conserved gene cluster among 
dermatophytes that are homologous to one that produces an immunosuppressive polyketide in 
Aspergillus fumigatus. Using a recombination-based cloning strategy in yeast, we constructed 
fungal heterologous expression vectors that encode the cryptic clusters. When integrated into the 
model Aspergillus nidulans host, a structurally related compound neosartoricin B was formed, 
suggesting a possible role of this compound in the pathogenesis of these strains.
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Secondary metabolites (SMs) play important roles in the pathogenesis of microorganisms. In 
pathogenic fungi, polyketide and nonribosomal peptides have been shown to be the potential 
virulence factors and immunosuppressants1-5. Identification of these factors is therefore 
highly important towards understanding the molecular basis of host-pathogen 
interactions6, 7. Genome sequencing of numerous dermatophytes belonging to the 
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Trichophyton and Arthroderma genera revealed that each genome encodes numerous SM 
clusters1,8. Unfortunately, under laboratory conditions many of the gene clusters in fungi are 
silent and hence mask the products encoded in them 9. The difficulties involved in 
manipulating these fungi, such as long doubling times and lack of genetic tools, further 
impedes the establishment of metabolite-cluster correlations.
When analyzing the polyketide gene clusters from the sequenced dermatophyte genomes1, 8, 
we found an orthologous gene cluster, which is also conserved in pathogenic fungi 
Aspergillus fumigatus and Neosartorya fischeri 10, 11(Figure 1). In each genome, the cluster 
contains a set of four genes that includes polyketide synthase (PKS), a β-lactamase like 
thioesterase (TE), a flavin-dependent monooxygenase (FMO) and a polycyclic 
prenyltransferase (pcPT) 10, 11. In addition to these four well-conserved “core PKS genes”, 
the neighboring regions encode additional genes, some of which are highly syntenic and 
conserved between genomes (Figure 1). We recently showed that when activated, these core 
PKS genes from A. fumigatus and N. fischeri can synthesize a prenylated, tricyclic 
polyketide neosartoricin11. Neosartoricin was shown to inhibit T-cell proliferation with an 
IC50 of 3 μM and was proposed to possibly play a role in suppressing host adaptive immune 
response during infection11. The conservation of the core PKS genes in the dermatophytes 
(>90% identity between them) (Table S3, Supplementary Information), and the lower 
sequence homology to those in A. fumigatus and N. fischeri (~70% identity, Table S3), raise 
an interesting question as to whether these fungi produce similar compounds, and whether 
the presence of additional conserved genes may lead to further tailoring of the neosartoricin 
scaffold.
To examine the activities of the conserved core PKS genes from dermatophytes, we cloned 
the clusters using yeast recombination12 followed by expression in Aspergillus nidulans 
(Figure S1, Supplementary Information). We initiated the cloning strategy by creating an E. 
coli-yeast-Aspergillus shuttle vector, pYH-wA-pyrG, which consists of a ColE1 origin of 
replication from SuperCos1, a yeast centromere sequence (CEN) and an autonomously 
replicating sequence (ARS) 13, 14 (Table S1, Materials and Methods). The choice of the low 
copy number in Saccharomyces cerevisiae allows stable maintenance of the subsequent 
large (>20 kb) plasmids containing cloned gene clusters. For fungal heterologous 
expression, we used the well-studied A. nidulans containing the ΔnkuA deletion (Table S1), 
which minimizes non-homologous recombination events15, 16. The wA locus in A. nidulans, 
which encodes a pigment-encoding and nonessential PKS17, was chosen as the site for 
homologous integration of the gene clusters (Figures 2 and S1B). This allowed the facile, 
initial screening of correct recombination through visual evaluation of the resulting white 
conidia.
Using in vivo yeast recombination cloning (Figure S1A), the core PKS genes 
(TESG_6702-6705), along with a putative pathway specific fungal transcription factor (TF, 
TESG_6706) (Figure 1) from Trichophyton tonsurans was cloned into the pYH-wA-pyrG 
vector adjacent to the A. fumigatus pyrG (AfpyrG) selection marker. The entire cassette was 
flanked by upstream and downstream sequences of the wA gene (Figure S1A). The native 
promoter of the TF (TESG_6706) gene was replaced with the A. nidulans gpdA promoter. 
The use of the constitutive promoter is to ensure expression of the foreign gene cluster in A. 
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nidulans, since neosartoricin-like compounds are not isolated from the dermatophytes under 
a variety of culture conditions (data not shown). The resultant plasmid containing the four 
core PKS genes was then linearized and introduced into A. nidulans. A number of the 
nutrition-complemented transformants displayed the loss of the green spore pigments 
associated to the wA mutant phenotype. In addition, a yellow pigmentation was observed for 
these mutants, which is similar to the N. fischeri strain overexpressing neosartoricin in our 
previous study 11 (Figure S2).
Following PCR verification of the integration of all four genes, the strain TWY1.1 
(TESG_06702-6706) was cultivated in GMM media with 0.5 μM pyridoxine HCl; and the 
metabolites were extracted and analyzed with LC-MS (Figure 3). Compared to the isogenic 
control TWY2.2 (ΔwAPKS) in which the wA locus was disrupted with the pyrG cassette 
alone, a new metabolite (yield 10 mg/L) was observed with UV absorption identical to that 
of neosartoricin. Mass analysis showed that the compound has m/z = 443 [M+H]+ (Figure 
S3C), which is 42 mass units (mu) lower than that of neosartoricin. The new metabolite 
(hereafter named neosartoricin B) was purified from the crude extract and fully 
characterized by one and two-dimensional NMR analyses (Table S4 and Supplementary 
NMR spectra). Neosartoricin B is structurally similar to neosartoricin, with the loss of acetyl 
group at the C2 hydroxyl. All other structural features, including the polyhydroxylated 
aromatic scaffold, C5 prenylation and 1,3-diketo substituent at C3 were all verified to be 
identical. The C2 acetyl group in neosartoricin was attributed to the action of an unidentified 
and likely endogenous acetyltransferase in A. fumigatus. The absence of this group in 
neosartoricin B may be attributed to the lack of this activity in A. nidulans.
During purification of neosartoricin B, we observed that under slightly acidic conditions, 
neosartoricin B can be converted into two additional compounds neosartoricins C and D 
(Figure 3B), both of which have the molecular weight of 424 (Figure S4). Full structural 
characterizations were performed to reveal their structures as shown in Figure 3B. 
Interestingly, neosartoricin C is a spirocyclic compound that is cyclized through the attack 
of C3 hydroxyl on C14, followed by dehydration. On the other hand, neosartoricin D is a 
further cyclized compound in which attack of C2 on C14 in neosartoricin C resulted in the 
formation of the acetal-containing dioxabicyclo-octanone ring. Both of these compounds are 
novel and possibly represent related metabolites of the gene cluster. Indeed, analysis of the 
organic extract of TWY1.1 also revealed small amounts of neosartoricins C and D, although 
it is not known whether these are formed during culturing or during the extraction process.
Other highly identical and syntenic genes were found immediately adjacent to most of the 
core PKS gene ensembles in some of the dermatophytes, including T. tonsurans, T. 
equinum, T. verrucosum, and A. benhamiae (Figure 1). Among them include enzymes that 
one may anticipate to associate with the modification of secondary metabolites, including 
putative dioxygenase (DO), amino acid racemase (R) and alcohol dehydrogenase (ADH). 
Hence it appears tantalizingly possible that among these organisms, neosartoricin B may be 
further morphed into a different product that may have additional biological properties. To 
assess the possible roles of these enzymes in tailoring of neosartoricin B, we used a similar 
strategy to insert different combinations of these genes from T. tonsurans into the 
neosartoricin B-producing host TWY1.1 (Figure S1B). Specifically, we added 
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TESG06695-6701, TESG06695-6701 (without 6696) and TESG_06701 to yield TWY7.1, 
TWY8.1 and TWY9.1, respectively. However, follow-up analysis of the extracts from these 
strains yielded metabolic profiles identical to that of TWY1.1 (Figures 3 and S3A). This 
suggests that although highly conserved, the genes either may not express or do not co-
transcribe with the core PKS genes. Indeed, RT-PCR analysis of the genes TESG6698 and 
TESG6701 in TWY7.1 showed that the genes included in this cassette are not co-transcribed 
with the PKS-associated genes with the constitutively expressed TF (Figure S5), hence are 
likely not involved in the neosartoricin B pathway. Lastly, six contiguous genes in 
Arthroderma otae (Microsporum canis) (MCYG_03596-3602) including the four core PKS 
genes, a TF gene and a putative aminocyclopropane carboxylic acid synthase (ACCS) gene 
were also introduced into A. nidulans to create TWY3.3, which was confirmed to produce 
neosartoricin B as well (Figures 3 and S2).
Our discovery of neosartoricin B demonstrates that the highly conserved core PKS genes 
(PKS, TE, FMO and pcPT) in dermatophytes can synthesize nearly the same prenylated 
aromatic polyketide as in A. fumigatus and N. fischeri, of which we showed have notable 
immunosuppressive activities. Neosartoricin B may therefore mediate immunomodulatory 
interactions with the host during infection and colonization of the pathogenic fungi. The 
biosynthetic mechanism of neosartoricin B is expected to follow that proposed for 
neosartoricin11. Hence the neosartoricin compounds may represent conserved SM shared by 
pathogenic fungal strains. Our approach shows the potential to use the model fungus to 
analyze the products of biosynthetic pathways from difficult to handle organisms.
MATERIALS AND METHODS
Strain, media and growth conditions
The fungal strains used in this study are listed in the Supplementary Information Table S1. 
All strains were grown at 37°C on glucose minimum medium (GMM) 18 and when 
appropriate were supplemented with 0.56 g uracil L−1, 1.26 g uridine L−1, 0.5 μM 
pyridoxine HCl, and maintained as glycerol stocks at −80°C. Escherichia coli strains XL-1 
Blue (Stratagene) was used for DNA manipulation.
Gene cloning, plasmid construction and genetic manipulation
The plasmids utilized in this work are listed in Table S1. The oligonucleotide sequences for 
PCR primers are given in Table S2. PCR reactions were performed with Phusion high-
fidelity DNA polymerase (New England Biolabs). PCR screening for transformants and 
mutants were carried out with Quick-Load® Taq 2X Master Mix (New England Biolabs).
The basic strategy for assembling of large PCR fragments is splicing by overlapping 
extension (SOE)-PCR and yeast homologous recombination as described in Figure S1. 
Saccharomyces cerevisiae strain BJ5464-NpgA (MATα ura3-52 his3-Δ200 leu2-Δ1 trp1 
pep4::HIS3 prb1Δ1.6R can1 GAL) was used as the host12. The vector pYH-WA-pyrG is 
constructed by in vivo yeast recombination of three linear DNA fragments consisting of 1) 
the ColE1 origin of replication and ampR from SuperCos1 vector (Stratagene), 2) a yeast 
centromere sequence (CEN), autonomously replicating sequence (ARS) and a URA3 marker 
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from pXP742 19, and 3) a 5′wA-AfpyrG-3′wA cassette synthesized by fusion PCR. The 
pyrG auxotrophy marker was amplified from A. fumigatus genomic DNA, while the 5′ and 
3′ regions of the wA gene were amplified from A. nidulans genomic DNA. All three DNA 
fragments for in vivo yeast recombination contained a minimum of 35 bp overlapping bases 
with the flanking fragments. Primers used for construction of the plasmid are listed in Table 
S2.
Using the same strategy, all plasmids pWY13.2, 14.1, 15, 16 and 17.1 (Table S1) were 
constructed in this study. Overlapping regions between two flanking segments of 
TESG_06695-6706 and MCYG_03596-3602 ranged from 60-150 bp and overlapping 
regions between the segments and the vector pYH-WA-pyrG were 40 bp. Briefly, four PCR 
fragments (ca. 4 kb/ each fragment) of TESG_06706-6702 were amplified with T. tonsurans 
genomic DNA by using designated primers (Table S2) respectively. The gpdA promoter was 
amplified by using A. nidulans genomic DNA and fused with transcription factor (TF) 
TESG_06706 using designated primers (Table S2). Then, all the fragments, NheI digested 
vector were gel purified and transformed into S. cerevisiae BJ5464-NpgA by using S. c. 
EasyCompTM Transformation Kit (Invitrogen). The obtained yeast colonies were 
characterized by PCR. Yeast plasmids were isolated by using Zymoprep™ (D2001) Kit 
(Zymo Research) and transformed into E. coli XL1 Blue. The fragments for 
MCYG_03596-3602 from A. otae were assembled to create plasmid pWY14.2. For the 
construction of plasmids pWY15, 16 and 17.1, the selectable marker AfpyroA was amplified 
from A. fumigatus and assembled with NotI digested pYH-WA-pyrG, and amplified 
genomic DNA segments from the fungal hosts (Figure 1). All plasmids were confirmed by 
restriction enzyme digestion and sequencing.
Transformation of A. nidulans
A. nidulans strain RJMP1.49 was used as the recipient host. Fungal protoplast preparation 
and transformation were modified as the description from Bok and Keller20. The 
modifications are the following: 1) culture medium for conidia germination is reduced to 
20-50 mL and germination time is shortened. Inoculate 20-50 mL of sterile liquid Minimal 
Medium (LMM, containing the appropriate supplements) with about 5 × 108 fresh spores (1 
× 107 conidia mL−1) and shake at 37°C and 280 rpm for approximately 5-6 h for spore 
germination. The germination time can be shortened 1-2 h if yeast extract is added to 
medium. 2) Digestion temperature with lysing enzyme is adjusted to 37°C which can reduce 
digestion time 1-2 h. Optionally, digestion can also be performed at room temperature 
overnight to obtain better protoplasts. 5 to 15 micrograms of plasmids were linearized and 
transformed into RJMP1.49. Transformation with linearized pYH-WA-pyrG was used as 
control. Transformants were verified by using diagnostic PCR with appropriate primers 
(Table S2).
RNA extraction and reverse transcriptase PCR (RT-PCR)
106 spores from TWY2.1 (Isogenic control), TWY1.1, TWY3.3 and TWY7.1 were 
inoculated into 10 mL LMM with pyridoxine (0.5 μM) and cultivated at 37°C for 2 days 
under dark conditions with two replicates each. Then, the mycelia were harvested and total 
RNA was extracted using the Ambion RiboPure™-Yeast Kit according to the instructions 
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(Invitrogen, Carlsbad, CA). For transcription assessment of dermatophyte clusters in A. 
nidulans, the single strand cDNAs from TWY2.1, TWY1.1 TWY3.3 and TWY7.1 were 
synthesized by using ImProm-II™ Reverse Transcription System (Promega, Madison, WI). 
Genes coding for putative TF1 (TESG_06706), NR-PKS (TESG_06702), dioxygenase 
(TESG_06701) and asp/glu racemase (TESG_06698) were used for the transcription 
assessment of TESG_06695-6706 from T. tonsurans. Genes coding for putative TF1 
(MCYG_03602) and NR-PKS (MCYG_03598) were used for the assessment of 
MCYG_03596-3602 transcription from A. otae.
Fermentation and LC-MS analysis
A. nidulans strains were cultivated at 37°C in liquid GMM (supplemented with 0.5 μM 
pyridoxine HCl) at 1.0 × 105 spores per 10 cm plate in the dark. After 2 days, 700 μL 
cultures were taken from each strain and transferred to a 1.5 mL eppendorf tube. The 
cultures were extracted with 700 μL of ethyl acetate (EtOAc)/methanol (MeOH)/acetic acid 
(AcOH) (89:10:1). The organic phase was evaporated to dryness and re-dissolved in 100 μL 
MeOH. 10 μL of dissolved extract was injected for high performance liquid 
chromatography-photodiode array detection- mass spectrometry (HPLC-DAD-MS) analysis. 
LC-MS spectra were obtained on a Shimadzu 2010 EV liquid chromatography mass 
spectrometer using positive and negative electrospray ionization and a Phenomenex Luna 5 
μm, 2.0 mm X 100 mm C18 reverse-phase column. Samples were separated on a linear 
gradient of 5-95% acetonitrile (CH3CN) in water (0.1% formic acid) for 30 min at a flow 
rate of 0.1 mL/min followed by isocratic 95% CH3CN in water (0.1% formic acid) for 
another 15 min.
Neosartoricin B extraction and purification
Neosartoricin B was purified from 2 day TWY1.1 culture in stationary liquid GMM culture 
(100 mL/per plate, 10 plates) with 0.5 μM pyridoxine HCl. The compound was extracted 
from the cultures using equal volume of EtOAc/MeOH/AcOH (89:10:1) twice. After 
evaporation of the organic phase, the crude extracts were separated by a chromatographic 
step on a Sephadex LH-20 column using MeOH/chloroform (CHCl3) (9:1) as the mobile-
phase. Further purification was carried out by reverse phase HPLC using a Beckman Coulter 
System Gold LC with a Phenomenex Luna 250 × 10 mm 5 micron C18 column. The 
compounds were separated using a solvent gradient of 50-80% solvent B (CH3CN) at a flow 
rate of 2.5 mL/min over 30 min. Neosartoricins C and D were purified using the same 
procedures as described above except 0.1 % trifluoroacetic acid was added to the HPLC 
solvents. The HPLC fractions containing pure compounds were pooled and dried completely 
under vacuum before NMR analysis.
NMR characterization
All 1H, 13C and 2D (1H-13C HSQC and 1H-13C HMBC) NMR were performed on a Bruker 
DRX-500 spectrometer at the UCLA Department of Chemistry and Biochemistry NMR 
facility. CDCl3 was used as the solvent for neosartoricin B, C and D.
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Comparison of conserved gene clusters across different dermatophyte and pathogenic fungi. 
All of the fungi shown contain a conserved core PKS gene cassette that consists of a 
nonreducing polyketide synthase (NR-PKS), β-lactamase thioesterase (TE), flavin-
dependent monooxygenase (FMO) and polycyclic prenyltransferase (pcPT). A fungal 
transcription factor (TF) is also found immediately adjacent to the core PKS genes. In 
dermatophytes, additional genes are also found adjacent to the core PKS gene cassette, 
among which many are conserved across different fungi. Some of the genes include 
dioxygenase (DO), hypothetical protein (HP), amino acid racemase (R), major facilitator 
superfamily transporters (MFS) and alcohol dehydrogenase (ADH). In A. otae, an additional 
C6 transcriptional factor (TF2) is adjacent to the core PKS gene cassette.
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The strategy for integrating dermatophyte gene cluster into A. nidulans. The dermatophyte 
genes were cloned between A. nidulans wA flanking regions and then integrated into wA 
locus by replacing the wAPKS gene.
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The production of neosartoricins from synthetic mutants in A. nidulans. (A) HPLC traces 
(400 nm) of organic extracts from different strains. Trace 1: isogenic control TWY2.2; Trace 
2: TWY1.1 (TESG_06702 to 6706); Trace 3: TWY7.1 (TESG_0695 to 6706); and Trace 4: 
TWY3.3 (MCYG_03596 to 3602). (B) The structures of neosartoricin, neosartoricins B, C 
and D.
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